Pharma Journalist -

SERB Pharmaceuticals, a global specialty pharma company focused on rare diseases and medical emergencies, announced it has entered a definitive agreement to acquire Y-mAbs Therapeutics,…
Read More...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental biologics license application (sBLA) for Breyanzi (lisocabtagene…
Read More...

Agios Pharmaceuticals, Inc. announced that the Saudi Food and Drug Authority (SFDA) has approved PYRUKYND (mitapivat) for the treatment of adult patients with non-transfusion-dependent…
Read More...

Atombeat Inc., a leader in AI-driven drug discovery, and BioDuro, a global contract research, development, and manufacturing organization (CRDMO), have announced a strategic partnership…
Read More...

Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS, including its state-of-the-art J.POD biologics development and…
Read More...

Repligen Corporation has announced a strategic partnership with Novasign aimed at accelerating the digital transformation of bioprocessing. The collaboration will focus on integrating…
Read More...

Altasciences and VoxCell BioInnovation have announced a strategic collaboration aimed at transforming preclinical drug development by integrating advanced 3D bioprinted tissue models…
Read More...

Eli Lilly and Company has announced positive topline results from its landmark SURPASS-CVOT trial, a large-scale Phase 3 study comparing two widely used diabetes drugs—Mounjaro…
Read More...

Since announcing their partnership in April 2025, AstraZeneca and Revna Biosciences have made significant strides in improving lung cancer care across Ghana, from early diagnosis to…
Read More...

Viridian Therapeutics, Inc. has announced a major collaboration and license agreement with Kissei Pharmaceutical Co., Ltd. to develop and commercialize two investigational therapies —…
Read More...